$ISR bottom Pr $1.38 called 3/18/14 $1.21 Is

$ISR bottom Pr $1.38
called 3/18/14 $1.21

Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer
2014-10-07 08:07 ET - News Release
RICHLAND, WA(Eteligis Inc.)



Website

Shares Outstanding: 54.69M
Float: 54.01M



10-K 8/29/14
Summary


Headlines

Tuesday, October 7, 2014
Why IsoRay (ISR) Stock Is Surging Todayat TheStreet
8:17 am IsoRay announces early success for young Peruvian girl utilizing Cesium-131 in first Stereotactic implant for inoperable brain cancerBriefing.com
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain CancerMarketwired
Saturday, October 4, 2014
ISORAY, INC. FinancialsEDGAR Online Financials

Tuesday, September 30, 2014
IsoRay, Inc. Reports Fiscal Year 2014 ResultsMarketwired
ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online

Monday, September 29, 2014
ISORAY, INC. Files SEC form 10-K, Annual ReportEDGAR Online

Friday, September 19, 2014
Stocks Creating Buzz TodayAccesswire

Thursday, September 18, 2014
IsoRay Has Tremendous Potential Gaining More Published Peer ReviewsAccesswire

Tuesday, September 9, 2014
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO)Marketwired

Thursday, September 4, 2014

ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online
Wednesday, August 20, 2014
Medical Device Stocks ReportAccesswire

Thursday, August 14, 2014
ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online

Thursday, August 7, 2014
ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online

Tuesday, August 5, 2014
IsoRay Announces Positive Peer Review Of Cesium-131 In Treatment Of Metastatic Brain CancerBenzinga
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of NeurosurgeryMarketwired

Wednesday, July 23, 2014
Top Biotechnology StocksAccesswire

Monday, July 14, 2014
Why IsoRay (ISR) Stock Is Spiking Todayat TheStreet
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in PeruMarketwired

Monday, June 30, 2014
IsoRay Announces Its Addition to the Russell Microcap IndexMarketwired

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP